Adding Allergan to my long-term 50 Stocks portfolio on the strength of its Botox franchise
Today’s buy for Allergan (AGN) in my long-term 50 Stocks portfolio completes the transition I started when I sold the stock in my 12-18 month Jubak’s Picks portfolio. At the time of that sell, I felt that Allergan was chasing too many opportunities that...
Selling Allergan out of my 12-18 month Jubak Picks portfolio; will be adding it to long-term 50 Stocks portfolio
I still like Allergan’s (AGN) portfolio of anti-aging drugs, especially it’s Botox franchise. But I’m not especially fond of the company’s current strategy of acquisitions in the very hot market for NASH drugs. Yes, someone will win a key...
Two acquisitions in a day: What is Allergan up to?
Update September 23, 2016 Allergan (AGN), which I added to my Jubak’s Picks portfolio on July 30, 2015 on the strength of its Botox franchise, acquired two companies on September 20. Neither is in the Botox or cosmetic drugs space. Both, in fact, are companies...Allergan’s earnings report today says there’s life after the collapse of the Pfizer deal
Update May 10. Allergan (AGN) reported first quarter 2016 earnings and revenue today. These results are really the first chance that investors in Allergan have to assess the state of the company since its merger with Pfizer (PFE) died at the hands of changes in tax...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!